Markets · Europe · XETRA

BAYN.DE Bayer

€42.59 -3.14%

Europe · Pharmaceuticals

Log

Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.

-3.14%

YTD

+55.30%

P/E

—

P/B

—

ROE

—

Div yield

—

Beta

0.42

Market cap

—

RSI (14)

Next earnings

—

Previous session

close of Oct 8, 2026 · EOD, no live order book

Open

€43.45

€42.59

VWAP (n/a)

—

Day high

€43.69

Day low

€42.59

Volume

2.5M

VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.

Latest headlines

Bayer to Present New Cardiac Amyloidosis and Heart Failure Data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting

Yahoo Finance · Oct 8

Bayer Seeks Kerendia Label Expansion in Non-Diabetic CKD

Yahoo Finance · Oct 8

Chronic Pulmonary Hypertension Market Insights, Epidemiology, and Market Forecast - 2036 Report Reveals Why a Limited Pipeline Leaves the 7MM Market Without a Curative Leader

Yahoo Finance · Oct 8

FDA accepts Bayer’s Kerendia filing for kidney disease without diabetes

Yahoo Finance · Oct 8

U.S. FDA Accepts Bayer’s Supplemental New Drug Application for KERENDIA® (finerenone) to Treat Adults with Chronic Kidney Disease (CKD) Without Diabetes

Yahoo Finance · Oct 8

Bayer Eyes $2.2B Pharmaceutical Campus in New Albany

Yahoo Finance · Oct 7

Headlines via Yahoo Finance · links open the source · not an endorsement.

Research & reports

TradingView ↗

Charts & analysis

Yahoo Finance ↗

Quote & news

External resources — availability and opinions are theirs, not ours.

This is reference data for your own analysis — not a recommendation to buy or sell BAYN.DE. Try it in the Lab to size a position and see the risk.